Article Abstract

Therapeutic potential of osimertinib in the treatment of lung cancer with HER2 aberrations

Authors: Guo-Qing Qian, Shi-Yong Sun

Abstract

Lung cancer remains a leading cause of cancer-related mortality in both male and female worldwide. Non-small cell lung cancer (NSCLC) including adenocarcinoma, squamous cell carcinoma and large cell carcinoma constitutes the majority of lung cancer (~85%) cases.